The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Methylated ctDNA as a biomarker for detecting previously undetectable clinically significant somatic mutations.
 
Patrick Peiyong Ye
Employment - BillionToOne; BillionToOne (I)
Stock and Other Ownership Interests - BillionToOne
Patents, Royalties, Other Intellectual Property - BillionToOne (Inst)
 
Brian D. Woodward
No Relationships to Disclose
 
Sydne Langpap
Employment - BillionToOne
Stock and Other Ownership Interests - BillionToOne
 
Robb Viens
Employment - BillionToOne
Stock and Other Ownership Interests - BillionToOne
 
Katherine Shelburne
Employment - BillionToOne
 
Wen Zhou
Employment - 10X Genomics; BillionToOne
Stock and Other Ownership Interests - BillionToOne
 
Joyce Zhu
Employment - BillionToOne
 
Jan Wignall
Employment - BillionToOne
 
Naomi Searle
Employment - BillionToOne
 
Matthew Gordon Varga
Employment - BillionToOne
 
Gary A. Palmer
Employment - BillionToOne
Leadership - N-Power Medicine
Stock and Other Ownership Interests - Tempus
 
David Tsao
Employment - BillionToOne
Leadership - BillionToOne
Stock and Other Ownership Interests - BillionToOne
Patents, Royalties, Other Intellectual Property - BillionToOne
 
Oguzhan Atay
Employment - BillionToOne
Leadership - BillionToOne
Stock and Other Ownership Interests - BillionToOne
Patents, Royalties, Other Intellectual Property - BillionToOne
 
Hatim Husain
Consulting or Advisory Role - AstraZeneca; Blueprint Medicines; Foundation Medicine; Janssen; NeoGenomics Laboratories; PierianDx; PierianDx; Turning Point Therapeutics
Speakers' Bureau - AstraZeneca; Janssen
Research Funding - Bristol-Myers Squibb (Inst); Lilly (Inst); Pfizer (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Foundation Medicine; Janssen